isvav_result

publication_year

occurrences__organization__code

solver__id__sc2

result_type__code

Type of result according to the RIV classification. Czech version is available <a href="https://www.vyzkum.cz/FrontClanek.aspx?idsekce=1395" target="_blank" >here</a>.

language__code

Jazyk výsledku udáva původní jazyk, ve kterém byl daný výsledek vytvořen. Kompletní seznam jazyků ve kterém je možno výsledek do RIV předložit je <a href="https://www.vyzkum.cz/FrontClanek.aspx?idsekce=1397" target="_blank" >zde</a>.

cep__code

ford__code

_group_id67

occurrences__funder__code

Data supplier is the R&D aid provider who supported this result.

project__programme__code

x_range_count_solvers

project__id

What are you looking for?

Quick search

Smart search

Filters

Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases

The Safety Profiles of Adalimumab, Infliximab, Etanercept, Secukinumab and Ustekinumab in Psoriasis – A 30-month Observational Cohort Prospective Study of Adverse Events in Biologic Therapy

Novinky v léčbě psoriázy biologiky a standardními systémovými léky

The safety profile of biologic agents in comparison with non-biologic systemic agents, and topical compounds in the management of psoriasis - a 30-month prospective, observational cohort study

Význam biologických a psychosociálních faktorů pro rozvoj a chronicitu bolestí zad

Současné postavení biologik v léčbě psoriázy

Psoriasis Treatment with Adalimumab in Clinical Practice: Long-term Experience in a Center for Biological Therapy in the Czech Republic

Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent.

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

An Effective Detection of Conductivity Changes in Biologic Tissue